Location: Cambridge Horizon’s Glutamine Synthetase-Knockout CHO K1 cell line has been used as part of a successful Investigational New Drug filing with the FDA Filing further validates the use of Horizon’s Bioproduction cell line platform for the manufacture of biotherapeutics Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader […]

Samples to be collected from over 25,000 participants in Nurses’ Health Study II (NHSII) cohort BETHLEHEM, PA. – DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services, today announced that the Harvard T.H. Chan School of Public Health has selected DNA Genotek’s OMNIgene® family of microbiome collection devices to provide reliable […]

FARMINGDALE, N.Y. – EpiGentek, a NY-based biotechnology firm specializing in epigenetic research products and services, announced its technological and financial support for new skincare startup EpigenCare. William Lee, who served as an operations executive for a number of years at EpiGentek, spearheads EpigenCare’s venture as its CEO. EpiGentek will work in collaboration with EpigenCare to […]

Boston – The Pistoia Alliance, a global alliance of life science companies, vendors, publishers and academic groups, and Scilligence Corporation are pleased to announce the release of the major new extension to the HELM Web Editor. New functionalities enable the editor to support the representation of biomolecules with some structural uncertainty or ambiguity and also adds […]

SAN FRANCISCO — Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National Cancer Institute, along with agreements with research groups at three other academic and pharma institutions, to demonstrate the clinical utility of their immune-profiling assay, Cofactor Paragon. These research collaborations are centered […]

Exclusive two-way licensing deal promises to accelerate growth for both companies Frederick, MD — Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to reaserchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class […]

Funding will support new manufacturing facility, commercial expansion, and development of new innovative products. Oxford, UK. Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were raised from global investors including GIC (Singapore), CCB International (CCBI, China), Hostplus (Australia), and existing investors. The […]

Three industry leaders join company ranks to drive genomic discovery SAN DIEGO — Luna DNA, the first community owned genomic and medical research database, today announced the addition of three new members to its leadership team. The key hires in the VP of marketing and VP of business strategy and operation roles were filled by Aaron Mendes and Debora Thompson, […]

Payors reimburse first NGS, FDA-approved test for non-small cell lung cancer to expedite targeted therapy selection for patients CARLSBAD, Calif. — Thermo Fisher Scientific today announced its Oncomine Dx Target Test has been approved for coverage by the Centers for Medicare & Medicaid Services (CMS) as part of the agency’s national coverage determination (NCD) for next-generation sequencing (NGS) […]

CARLSBAD, Calif. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired IntegenX Inc., which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly enhance Thermo Fisher’s existing HID portfolio and complement its leading human identification chemistries, as well as its qPCR and capillary electrophoresis systems. IntegenX […]